Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| oligodendrocyte | 11 studies | 26% ± 9% | |
| ciliated cell | 7 studies | 27% ± 7% | |
| epithelial cell | 3 studies | 27% ± 8% | |
| GABAergic neuron | 3 studies | 28% ± 4% | |
| glutamatergic neuron | 3 studies | 40% ± 2% | |
| astrocyte | 3 studies | 19% ± 2% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 5 studies | 30% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 99% | 1317.01 | 242 / 245 | 99% | 44.02 | 499 / 502 |
| thymus | 100% | 1511.44 | 652 / 653 | 97% | 20.59 | 588 / 605 |
| kidney | 100% | 1630.26 | 89 / 89 | 97% | 28.86 | 872 / 901 |
| intestine | 100% | 1566.47 | 966 / 966 | 95% | 21.39 | 503 / 527 |
| brain | 100% | 2306.26 | 2636 / 2642 | 95% | 27.44 | 668 / 705 |
| stomach | 100% | 1513.16 | 358 / 359 | 94% | 19.41 | 269 / 286 |
| pancreas | 99% | 1038.00 | 324 / 328 | 94% | 18.51 | 167 / 178 |
| breast | 100% | 1840.64 | 458 / 459 | 92% | 25.05 | 1024 / 1118 |
| adrenal gland | 98% | 1298.79 | 253 / 258 | 89% | 31.75 | 204 / 230 |
| lung | 99% | 2577.92 | 575 / 578 | 86% | 22.56 | 992 / 1155 |
| bladder | 100% | 1281.52 | 21 / 21 | 75% | 13.61 | 379 / 504 |
| liver | 87% | 622.38 | 197 / 226 | 73% | 11.22 | 296 / 406 |
| ovary | 47% | 302.18 | 84 / 180 | 97% | 15.82 | 417 / 430 |
| esophagus | 72% | 1285.17 | 1043 / 1445 | 67% | 16.29 | 123 / 183 |
| uterus | 75% | 478.86 | 127 / 170 | 51% | 9.34 | 235 / 459 |
| blood vessel | 100% | 3634.69 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 100% | 2519.44 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 1481.15 | 241 / 241 | 0% | 0 | 0 / 0 |
| adipose | 100% | 2270.57 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| heart | 97% | 1649.07 | 839 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 90% | 13.72 | 26 / 29 |
| skin | 57% | 375.24 | 1033 / 1809 | 32% | 4.15 | 152 / 472 |
| tonsil | 0% | 0 | 0 / 0 | 47% | 8.16 | 21 / 45 |
| peripheral blood | 45% | 789.33 | 419 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 3% | 0.15 | 2 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007596 | Biological process | blood coagulation |
| GO_0046130 | Biological process | purine ribonucleoside catabolic process |
| GO_0030194 | Biological process | positive regulation of blood coagulation |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0016020 | Cellular component | membrane |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0101003 | Cellular component | ficolin-1-rich granule membrane |
| GO_0047710 | Molecular function | bis(5'-adenosyl)-triphosphatase activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | ENPP4 |
| Protein name | Alternative protein ENPP4 Bis(5'-adenosyl)-triphosphatase ENPP4 (EC 3.6.1.29) (AP3A hydrolase) (AP3Aase) (Ectonucleotide pyrophosphatase/phosphodiesterase family member 4) (E-NPP 4) (NPP-4) |
| Synonyms | KIAA0879 NPP4 |
| Description | FUNCTION: Hydrolyzes extracellular Ap3A into AMP and ADP, and Ap4A into AMP and ATP. Ap3A and Ap4A are diadenosine polyphosphates thought to induce proliferation of vascular smooth muscle cells. Acts as a procoagulant, mediating platelet aggregation at the site of nascent thrombus via release of ADP from Ap3A and activation of ADP receptors. . |
| Accessions | Q9Y6X5 ENST00000321037.5 L8ECF4 |
